Home › AmpliPhi Biosciences' CEO To Discuss Novel Approaches To Fighting Drug-Resistant Pathogens In Panel At BIO International
 

Keywords :   


AmpliPhi Biosciences' CEO To Discuss Novel Approaches To Fighting Drug-Resistant Pathogens In Panel At BIO International

2016-06-01 05:37:22| drugdiscoveryonline Home Page

AmpliPhi Biosciences Corporation , a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections, recently announced that M. Scott Salka, AmpliPhi’s Chief Executive Officer, will participate in a panel discussion at this year’s BIO International Convention

Tags: international panel discuss bio

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.05WasteExpo 2024 Day One Preview: Welcome to Vegas!
06.05Brigade Electronics to Bring Virtual Reality to Its Stand at WasteExpo 2024
06.05The Story of a Sustainable Future: e2AS
06.05Biomaxs Rapid Thermophilic Digester Brings Tech to Organic Waste
06.05Keter Environmental Services and Waste Harmonics Name Bob Boucher as CEO
06.05Heineken to reopen more than 60 closed pubs
06.05What's this growing season hold? Are any weather extremes likely?
06.05Qantas agrees payouts over 'ghost flights'
More »